RE-VERSE-AD Trademark

Trademark Overview

On Wednesday, November 5, 2014, a trademark application was filed for RE-VERSE-AD with the United States Patent and Trademark Office. The USPTO has given the RE-VERSE-AD trademark a serial number of 79159630. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 5, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The RE-VERSE-AD trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Publication of printed matter with the results of clinical studies involving pharmaceutical preparations

Medical and scientific research in the field of haemostasis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
re-verse-ad

General Information

Serial Number79159630
Word MarkRE-VERSE-AD
Filing DateWednesday, November 5, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 5, 2024
Registration Number4766642
Registration DateTuesday, July 7, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPublication of printed matter with the results of clinical studies involving pharmaceutical preparations
Goods and ServicesMedical and scientific research in the field of haemostasis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, November 4, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, November 4, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, February 5, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 10, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2015ASSIGNED TO EXAMINER
Friday, February 13, 2015NON-FINAL ACTION WRITTEN
Saturday, February 14, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 17, 2015REFUSAL PROCESSED BY MPU
Tuesday, February 17, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 24, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 2, 2015PAPER RECEIVED
Friday, March 6, 2015REFUSAL PROCESSED BY IB
Monday, March 9, 2015ASSIGNED TO LIE
Monday, March 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 1, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2015AMENDMENT FROM APPLICANT ENTERED
Monday, March 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 17, 2015NOTIFICATION PROCESSED BY IB
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 7, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 2, 2015FINAL DISPOSITION PROCESSED
Friday, November 20, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 7, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, November 2, 2015FINAL DISPOSITION NOTICE SENT TO IB
Sunday, February 13, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 30, 2025DEATH OF INTERNATIONAL REGISTRATION
Friday, May 30, 2025NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, July 7, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, July 7, 2021TEAS SECTION 71 & 15 RECEIVED
Monday, March 14, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, March 14, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Related Keywords

verse field research medical scientific clinical trials pharmaceuticals information haemostasis providing